These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33921758)

  • 21. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.
    Sideri A; Stavrakis D; Bowe C; Shih DQ; Fleshner P; Arsenescu V; Arsenescu R; Turner JR; Pothoulakis C; Karagiannides I
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G591-604. PubMed ID: 25591865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases.
    Barbier M; Vidal H; Desreumaux P; Dubuquoy L; Bourreille A; Colombel JF; Cherbut C; Galmiche JP
    Gastroenterol Clin Biol; 2003 Nov; 27(11):987-91. PubMed ID: 14732844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Metabolic aspects" in inflammatory bowel diseases.
    Kaser A; Tilg H
    Curr Drug Deliv; 2012 Jul; 9(4):326-32. PubMed ID: 22023201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study.
    Zulian A; Cancello R; Ruocco C; Gentilini D; Di Blasio AM; Danelli P; Micheletto G; Cesana E; Invitti C
    PLoS One; 2013; 8(10):e78495. PubMed ID: 24205244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity.
    Portela ND; Galván C; Sanmarco LM; Bergero G; Aoki MP; Cano RC; Pesoa SA
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of adipose tissue in the pathogenesis of Crohn's disease.
    Zielińska A; Siwiński P; Sobolewska-Włodarczyk A; Wiśniewska-Jarosińska M; Fichna J; Włodarczyk M
    Pharmacol Rep; 2019 Feb; 71(1):105-111. PubMed ID: 30513401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory Diseases of the Gut.
    Rohr M; Narasimhulu CA; Sharma D; Doomra M; Riad A; Naser S; Parthasarathy S
    J Med Food; 2018 Feb; 21(2):113-126. PubMed ID: 29389238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptides, mesenteric fat, and intestinal inflammation.
    Karagiannides I; Pothoulakis C
    Ann N Y Acad Sci; 2008 Nov; 1144():127-35. PubMed ID: 19076372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
    Hill JH; Solt C; Foster MT
    Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation.
    Barchetta I; Cimini FA; Ciccarelli G; Baroni MG; Cavallo MG
    J Endocrinol Invest; 2019 Nov; 42(11):1257-1272. PubMed ID: 31073969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipokines in the pathogenesis of idiopathic inflammatory bowel disease.
    Olszanecka-Glinianowicz M; Handzlik-Orlik G; Orlik B; Chudek J
    Endokrynol Pol; 2013; 64(3):226-31. PubMed ID: 23873428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
    Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
    Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creeping Fat in the Pathogenesis of Crohn's Disease: An Orchestrator or a Silent Bystander?
    Tsounis EP; Aggeletopoulou I; Mouzaki A; Triantos C
    Inflamm Bowel Dis; 2023 Nov; 29(11):1826-1836. PubMed ID: 37260352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose tissue and inflammatory bowel disease pathogenesis.
    Fink C; Karagiannides I; Bakirtzi K; Pothoulakis C
    Inflamm Bowel Dis; 2012 Aug; 18(8):1550-7. PubMed ID: 22407798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of adipose tissue derived genes in endogenous Cushing's syndrome versus diet-induced obesity.
    Denes J; Zsippai A; Kovacs L; Gorombey Z; Kovacs GL; Goth M; Igaz P; Hubina E
    Endokrynol Pol; 2019; 70(2):131-134. PubMed ID: 30480750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus.
    Cianci R; Franza L; Massaro MG; Borriello R; Tota A; Pallozzi M; De Vito F; Gambassi G
    Curr Med Chem; 2022; 29(18):3189-3201. PubMed ID: 34986766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and novel management of inflammatory bowel disease.
    Kim JH; Oh CM; Yoo JH
    World J Gastroenterol; 2023 Mar; 29(12):1779-1794. PubMed ID: 37032724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases.
    Theocharidou E; Balaska A; Vogiatzis K; Tellis CC; Gossios TD; Athyros VG; Tselepis AD; Karagiannis A
    Inflamm Bowel Dis; 2016 Sep; 22(9):2206-12. PubMed ID: 27508511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Obesity on Inflammatory Bowel Disease.
    Khakoo NS; Ioannou S; Khakoo NS; Vedantam S; Pearlman M
    Curr Gastroenterol Rep; 2022 Jan; 24(1):26-36. PubMed ID: 35150406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipokines and the role of visceral adipose tissue in inflammatory bowel disease.
    Karrasch T; Schaeffler A
    Ann Gastroenterol; 2016; 29(4):424-438. PubMed ID: 27708507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.